Price Targets: Developments for Vinci, Eiffage, Alstom...
This Wednesday, eleven cases were subject to revisions by analysts, with significant adjustments in infrastructure and health sectors. Target price changes range from -84% for MAAT Pharma to +24% for Eiffage.
Above their target: 3 values · Covered values: 62
Values above their target: BE SEMICONDUCTOR (-5.6%) · NN GROUP (-3.7%) · AGEAS (-1.9%)
Largest target / price gaps:
ESSILORLUXOTTICA — target 300.00 euros — target / price gap: +74.3%
CSG — target 31.75 euros — target / price gap: +68.8%
PROSUS — target 66.00 euros — target / price gap: +68.0%
WOLTERS KLUWER — target 100.00 euros — target / price gap: +65.6%
EXOR NV — target 109.00 euros — target / price gap: +64.5%
Vinci: Citi downgrades its recommendation from 'buy' to 'neutral' and lowers the target from 140 to 133 euros. An analyst had however raised their target on May 19. Median of targets at 144 euros — target / price gap: +16.0%.
Stellantis NV: UBS confirms its 'buy' but adjusts the target from 9.70 to 9.50 euros. One analyst had raised, another lowered their respective targets in the last 10 days.
MAAT Pharma undergoes a drastic cut: Stifel downgrades the recommendation from 'buy' to 'hold' and drops the target from 19... to 3 euros.
From 18.20 to 21 euros at Getlink SE: Citi maintains its 'buy' and raises the target.
Eurofins Scient.: Oddo BHF remains neutral but revises the target from 70 to 67 euros.
Elior Group: Citi initiates coverage with a 'neutral' recommendation and a target at 2.40 euros. 6 analysts had lowered their targets in the last 10 days (last movement on May 26).
A significant revaluation for Eiffage: Citi switches from 'neutral' to 'buy' and boosts the target from 125 to 155 euros. The median consensus stands at 160 euros — target / price gap: +31.7%. An analyst had already raised their target on May 21.
Dassault Systemes: Berenberg confirms the 'buy' and raises the target from 23 to 24 euros.
Bureau Veritas: Oddo BHF maintains 'outperform' but reduces the target from 35 to 31 euros.
Alstom sees Oxcap Analytics maintain its 'market weight' while lowering the target from 27.40 to 21.40 euros. An analyst had already lowered their target on May 19.
Aedifica: UBS maintains 'buy' and raises the target from 73 to 79 euros.
